恢复期血浆-话题@MedSci

#恢复期血浆#

15篇内容 | 780人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1587306, encodeId=ddcb158e306cc, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=JAMA Netw Open：开发和验证治疗效益指数，以确定COVID-19住院患者谁可能受益于恢复期血浆, objectType=article, longId=294972, objectId=78fd2949e2c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78fd2949e2c5, replyNumber=0, likeNumber=38, createdTime=2022-02-02, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78fd2949e2c5, moduleTitle=JAMA Netw Open：开发和验证治疗效益指数，以确定COVID-19住院患者谁可能受益于恢复期血浆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78fd2949e2c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587305, encodeId=8721158e3054f, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=JAMA Netw Open：高滴度恢复期血浆对COVID-19肺炎住院患者发展为严重呼吸衰竭或死亡的影响, objectType=article, longId=292194, objectId=5fe02921949d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe02921949d, replyNumber=0, likeNumber=30, createdTime=2021-12-19, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe02921949d, moduleTitle=JAMA Netw Open：高滴度恢复期血浆对COVID-19肺炎住院患者发展为严重呼吸衰竭或死亡的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fe02921949d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587304, encodeId=5970158e304fd, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=国家卫健委：新冠肺炎康复者恢复期血浆临床治疗方案, objectType=article, longId=219551, objectId=ee7f2195510a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7f2195510a, replyNumber=0, likeNumber=35, createdTime=2021-11-01, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7f2195510a, moduleTitle=国家卫健委：新冠肺炎康复者恢复期血浆临床治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee7f2195510a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587303, encodeId=4cdc158e303e2, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=J Infectious Dis: 早期恢复期血浆治疗对非重症 COVID-19 住院的死亡率影响, objectType=article, longId=217396, objectId=f79821e3969f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f79821e3969f, replyNumber=0, likeNumber=42, createdTime=2021-09-23, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f79821e3969f, moduleTitle=J Infectious Dis: 早期恢复期血浆治疗对非重症 COVID-19 住院的死亡率影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f79821e3969f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587302, encodeId=ae8b158e3020a, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=Nat Med：COVID-19住院患者输注恢复期血浆的疗效, objectType=article, longId=216959, objectId=785121695986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=785121695986, replyNumber=0, likeNumber=25, createdTime=2021-09-12, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=785121695986, moduleTitle=Nat Med：COVID-19住院患者输注恢复期血浆的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=785121695986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587301, encodeId=3dc9158e3013b, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=NEJM：恢复期血浆不能降低高危门诊新冠肺炎患者病情进展风险, objectType=article, longId=216094, objectId=b8a521609446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8a521609446, replyNumber=0, likeNumber=30, createdTime=2021-08-22, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8a521609446, moduleTitle=NEJM：恢复期血浆不能降低高危门诊新冠肺炎患者病情进展风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8a521609446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587300, encodeId=d741158e300dd, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=柳叶刀：高滴度恢复期血浆并不能改善COVID-19住院患者的生存期或其他临床结局, objectType=article, longId=212153, objectId=7482212153a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7482212153a4, replyNumber=0, likeNumber=27, createdTime=2021-06-03, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7482212153a4, moduleTitle=柳叶刀：高滴度恢复期血浆并不能改善COVID-19住院患者的生存期或其他临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7482212153a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587299, encodeId=53f3158e299d8, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=金斯瑞新冠中和抗体检测试剂盒在美获授权用于恢复期血浆筛查，有助于提高恢复期血浆治疗的有效性, objectType=article, longId=206938, objectId=c5192069380a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5192069380a, replyNumber=0, likeNumber=32, createdTime=2021-02-10, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5192069380a, moduleTitle=金斯瑞新冠中和抗体检测试剂盒在美获授权用于恢复期血浆筛查，有助于提高恢复期血浆治疗的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5192069380a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587298, encodeId=0586158e298ef, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=NEJM：恢复期血浆治疗新冠肺炎，一波三折再现曙光！, objectType=article, longId=205728, objectId=3ca0205e284a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ca0205e284a, replyNumber=0, likeNumber=37, createdTime=2021-01-16, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ca0205e284a, moduleTitle=NEJM：恢复期血浆治疗新冠肺炎，一波三折再现曙光！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ca0205e284a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587297, encodeId=97a2158e29791, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=NEJM：早期高滴度恢复期血浆治疗可降低老年新冠肺炎感染者病情恶化风险, objectType=article, longId=205455, objectId=46de2054554a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46de2054554a, replyNumber=0, likeNumber=34, createdTime=2021-01-09, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46de2054554a, moduleTitle=NEJM：早期高滴度恢复期血浆治疗可降低老年新冠肺炎感染者病情恶化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46de2054554a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587296, encodeId=4f49158e296c4, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=NEJM：新冠患者的恢复期血浆——被高估的抗体治疗, objectType=article, longId=203733, objectId=c7a7203e33ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7a7203e33ab, replyNumber=0, likeNumber=41, createdTime=2020-11-27, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7a7203e33ab, moduleTitle=NEJM：新冠患者的恢复期血浆——被高估的抗体治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7a7203e33ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587295, encodeId=4406158e295db, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=BMJ：恢复期血浆用于中度新冠肺炎住院患者的治疗效果评估, objectType=article, longId=202534, objectId=64aa2025347a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64aa2025347a, replyNumber=0, likeNumber=33, createdTime=2020-10-28, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64aa2025347a, moduleTitle=BMJ：恢复期血浆用于中度新冠肺炎住院患者的治疗效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64aa2025347a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587294, encodeId=a3fd158e2943b, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=恢复期血浆疗法治疗重症新冠COVID-19感染患者：临床研究中显示出治疗潜力, objectType=article, longId=191701, objectId=f76a191e0100, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f76a191e0100, replyNumber=0, likeNumber=29, createdTime=2020-04-09, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f76a191e0100, moduleTitle=恢复期血浆疗法治疗重症新冠COVID-19感染患者：临床研究中显示出治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f76a191e0100)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587293, encodeId=29fd158e293c3, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=JAMA：恢复期血浆治疗COVID-19的可能性与挑战, objectType=article, longId=191167, objectId=98b019116ebf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98b019116ebf, replyNumber=0, likeNumber=35, createdTime=2020-04-02, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98b019116ebf, moduleTitle=JAMA：恢复期血浆治疗COVID-19的可能性与挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98b019116ebf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587292, encodeId=2488158e2926b, content=<a href='/topic/show?id=a6785283909' target=_blank style='color:#2F92EE;'>#恢复期血浆#</a>, objectTitle=NEJM：恢复期血浆真的能有效对抗埃博拉病毒吗？, objectType=article, longId=61850, objectId=edfd61850c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edfd61850c7, replyNumber=0, likeNumber=28, createdTime=2016-01-09, rootId=0, userName=doctorzheng, userId=f73917462216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edfd61850c7, moduleTitle=NEJM：恢复期血浆真的能有效对抗埃博拉病毒吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edfd61850c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

恢复期血浆

2020-05-29

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

JAMA Netw Open：开发和验证治疗效益指数，以确定COVID-19住院患者谁可能受益于恢复期血浆

2022-02-02

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

JAMA Netw Open：高滴度恢复期血浆对COVID-19肺炎住院患者发展为严重呼吸衰竭或死亡的影响

2021-12-19

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

国家卫健委：新冠肺炎康复者恢复期血浆临床治疗方案

2021-11-01

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

J Infectious Dis: 早期恢复期血浆治疗对非重症 COVID-19 住院的死亡率影响

2021-09-23

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

Nat Med：COVID-19住院患者输注恢复期血浆的疗效

2021-09-12

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

NEJM：恢复期血浆不能降低高危门诊新冠肺炎患者病情进展风险

2021-08-22

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

柳叶刀：高滴度恢复期血浆并不能改善COVID-19住院患者的生存期或其他临床结局

2021-06-03

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

金斯瑞新冠中和抗体检测试剂盒在美获授权用于恢复期血浆筛查，有助于提高恢复期血浆治疗的有效性

2021-02-10

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

NEJM：恢复期血浆治疗新冠肺炎，一波三折再现曙光！

2021-01-16

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

NEJM：早期高滴度恢复期血浆治疗可降低老年新冠肺炎感染者病情恶化风险

2021-01-09

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

NEJM：新冠患者的恢复期血浆——被高估的抗体治疗

2020-11-27

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

BMJ：恢复期血浆用于中度新冠肺炎住院患者的治疗效果评估

2020-10-28

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

恢复期血浆疗法治疗重症新冠COVID-19感染患者：临床研究中显示出治疗潜力

2020-04-09

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

JAMA：恢复期血浆治疗COVID-19的可能性与挑战

2020-04-02

doctorzheng (审核中...)

前往app查看评论内容

#恢复期血浆#

NEJM：恢复期血浆真的能有效对抗埃博拉病毒吗？

2016-01-09

科室
- - 订阅+
  - 更多科室
工具
服务